Immunocore Holdings (IMCR) Change in Receivables (2023 - 2026)

Immunocore Holdings has disclosed Change in Receivables across 4 years of filings, most recently posting $7.9 million for Q1 2026.

• Change in Receivables for Q1 2026 came in at $7.9 million, up 1048.56% year-over-year; the trailing twelve-month figure through Mar 2026 was $16.1 million (up 203.01% YoY), and the FY2025 annual result was $7.3 million, down 40.59% from the prior year.
• Change in Receivables came in at $7.9 million for Q1 2026 at Immunocore Holdings, up from -$2.0 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $10.2 million in Q4 2023 to a low of -$2.0 million in Q4 2025.
• The 4-year median for Change in Receivables is $3.6 million (2023), against an average of $3.5 million.
• Across the five-year window, Change in Receivables slumped 253.98% in 2025 and soared 1048.56% in 2026, its largest moves.
• Immunocore Holdings' Change in Receivables stood at $10.2 million in 2023, then plunged by 87.33% to $1.3 million in 2024, then plunged by 253.98% to -$2.0 million in 2025, then surged by 497.69% to $7.9 million in 2026.
• The last three Change in Receivables figures came in at $7.9 million (Q1 2026), -$2.0 million (Q4 2025), and $6.0 million (Q3 2025), per Business Quant data.